Order Article Reprints

Marascio N, Loria MT, Pavia G, Peronace C, Adams NJ, Campolo M, Divenuto F, Lamberti AG, Giancotti A, Barreca GS, et al. Evaluation of IL-35, as a Possible Biomarker for Follow-Up after Therapy, in Chronic Human Schistosoma Infection. Vaccines. 2023; 11(5):995. https://doi.org/10.3390/vaccines11050995

Marascio, Nadia, Maria Teresa Loria, Grazia Pavia, Cinzia Peronace, Neill James Adams, Morena Campolo, Francesca Divenuto, Angelo Giuseppe Lamberti, Aida Giancotti, Giorgio Settimo Barreca, and et al. 2023. "Evaluation of IL-35, as a Possible Biomarker for Follow-Up after Therapy, in Chronic Human Schistosoma Infection" Vaccines 11, no. 5: 995. https://doi.org/10.3390/vaccines11050995

Marascio, N., Loria, M. T., Pavia, G., Peronace, C., Adams, N. J., Campolo, M., Divenuto, F., Lamberti, A. G., Giancotti, A., Barreca, G. S., Mazzitelli, M., Trecarichi, E. M., Torti, C., Perandin, F., Bisoffi, Z., Quirino, A., & Matera, G. (2023). Evaluation of IL-35, as a Possible Biomarker for Follow-Up after Therapy, in Chronic Human Schistosoma Infection. Vaccines, 11(5), 995. https://doi.org/10.3390/vaccines11050995